SCHEMBL737313

SCHEMBL737313

c1cnn(C(n2cccn2)n2cccn2)c1

nearest known ligand 0.33

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 1/20 0.33
FBP1 P09467 1/20 0.32
FDPS P14324 1/20 0.31
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
G6PD P11413 1/20 0.31
KMT2A Q03164 1/20 0.31
NOTUM Q6P988 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2765928 0.89 NOTUM (0.30) NOTUM
Butadiene SCHEMBL2765168 0.85
SCHEMBL5713342 0.77 NOS1 (0.34) NOS1FBP1MEN1KMT2A
SCHEMBL6908293 0.77 NOS1 (0.31) NOS1FBP1
SCHEMBL2575521 0.77
SCHEMBL924323 0.77
SCHEMBL11094418 0.77
SCHEMBL174399 0.77
SCHEMBL6022879 0.75
Bromide SCHEMBL27878723 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026047173-A1 PROCESS FOR PREPARING SUSTAINABLE JET FUELS OR DIESEL FUELS; AND PRECURSORS THEREOF Terra Mater BV (BE) 2026-03-05 WO claimed
EP-4622945-A1 OLIGOMERISATION OF ALCOHOLS Terra Mater BV (BE) 2025-10-01 EP claimed
WO-2024110575-A1 OLIGOMERISATION OF ALCOHOLS Terra Mater BV (BE) 2024-05-30 WO claimed
CN-111001427-B Cobalt-nitrogen co-doped carbon-based electrocatalyst material and preparation method thereof 山西大学 2021-05-14 CN claimed
EP-2099452-B1 TRICARBONYL COMPLEXES WITH TRIDENTATE CHELATORS FOR MYOCARDIUM IMAGING MALLINCKRODT LLC (US) 2015-07-22 EP claimed
EP-2274312-B1 METAL COMPLEXES UNIV ZUERICH (CH) 2015-06-03 EP claimed
US-9023315-B2 Tricarbonyl complexes with tridentate chelators for myocardium imaging MALLINCKRODT LLC (US) 2015-05-05 US claimed
US-8961924-B2 Metal complexes UNIVERSITY OF ZURICH (CH) 2015-02-24 US claimed
US-8940273-B2 Tricarbonyl complexes with tridentate chelators for myocardium imaging MALLINCKRODT LLC (US) 2015-01-27 US claimed
EP-2708547-A1 AQUEOUS SOLUTIONS OF RADIOMETAL COMPLEXES WITH TRIDENTATE LIGENDS Universität Zürich (CH) 2014-03-19 EP claimed
US-20100074842-A1 Technetium-99m (I) Tricarbonyl Complexes with Tridentate Chelators for Myocardium Imaging LIEBEL-FLARSHEIM COMPANY LLC 2010-03-25 US claimed
EP-2122007-A1 METHOD FOR FORMING A FILM ON A SUBSTRATE Sixtron Advanced Materials, Inc. (CA) 2009-11-25 EP claimed
WO-2009112823-A2 METAL COMPLEXES Universität Zürich (CH) 2009-09-17 WO claimed
EP-2099452-A2 TRICARBONYL COMPLEXES WITH TRIDENTATE CHELATORS FOR MYOCARDIUM IMAGING Mallinckrodt Inc. (US) 2009-09-16 EP claimed
WO-2009050509-A2 COLORIMETRIC SENSING AND/OR DETECTION OF DNA SEQUENCES USING RUTHENIUM OR OSMIUM BIPYRIDINE COMPLEXES UNIVERSITY OF SHEFFIELD (GB) 2009-04-23 WO claimed
WO-2008104059-A1 METHOD FOR FORMING A FILM ON A SUBSTRATE SIXTRON ADVANCED MATERIALS, INC. (CA) 2008-09-04 WO claimed
WO-2008061792-A2 TRICARBONYL COMPLEXES WITH TRIDENTATE CHELATORS FOR MYOCARDIUM IMAGING MALLINCKRODT INC. (US) 2008-05-29 WO claimed
EP-0038756-B1 CATIONIC LIPOPHILIC COMPLEXES OF 99M TC USEFUL FOR MYOCARDIAL AND HEPATOBILIARY IMAGING Research Corporation (US) 1985-10-16 EP claimed
US-4387087-A RADIOLOGY; DIAGNOSIS/MEDICAL/ RESEARCH CORPORATION (US) 1983-06-07 US claimed
EP-0038756-A2 Cationic lipophilic complexes of 99m Tc useful for myocardial and hepatobiliary imaging Research Corporation (US) 1981-10-28 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100074842-A1 Technetium-99m (I) Tricarbonyl Complexes with Tridentate Chelators for Myocardium Imaging TNNT2, TNNI3, FABP3 NOS1 3728/4885FBP1 1229/4885FDPS 3275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.